Scorpius is a boutique CDMO with a fully operational clinical-scale biomanufacturing facility in San Antonio, Texas. The facility offers ~2,000 sq. ft. of process and analytical development space and ~8,600 sq. ft. of cGMP-compliant cleanroom manufacturing space. Biomanufacturing capabilities include upstream and downstream processing up to 500 L scale for mammalian and cell therapy-based products and up to 200 L scale for microbial-based products.

Our biomanufacturing services focus on accelerating product development timelines from pre-clinical evaluation to first-in-human studies and beyond in support of commercial manufacturing programs. By integrating analytical methods development, process development, cGMP manufacturing product characterization, and QC release testing, we can efficiently develop a client-specific clinical manufacturing solution that enables a faster path to clinical trials and product commercialization.